Engineering biomimetic bone marrow niche with gene modified mesenchymal stromal cells for ex vivo culture of human hematopoietic stem and progenitor cells
Abstract Background Hematopoietic Stem and Progenitor Cells (HSPCs) gene therapy has shown significant progress, with commercial approval for at least four distinct haematological disorders, and poised for a rapid expansion in the upcoming years. Despite these advancements, the ex vivo culture of HS...
Saved in:
| Main Authors: | Sevanthy Suresh, Vigneshwaran Venkatesan, Manoj Kumar K. Azhagiri, Gokulnath Mahalingam, Prathibha Babu Chandraprabha, Mohankumar K. Murugesan, Sanjay Kumar, Saravanabhavan Thangavel, Srujan Marepally |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Stem Cell Research & Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13287-025-04474-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Enhanced fetal hemoglobin production via dual-beneficial mutation editing of the HBG promoter in hematopoietic stem and progenitor cells for β-hemoglobinopathies
by: Prathibha Babu Chandraprabha, et al.
Published: (2024-12-01) -
Sickle cell disease: understanding pathophysiology, clinical features and advances in gene therapy approaches
by: Muhammad Taher, et al.
Published: (2025-08-01) -
Newborn screening for sickle cell anemia in Antalya, Türkiye
by: Zeynep Öztürk, et al.
Published: (2023-12-01) -
Hepatic stellate cells and their role in the formation of the progenitor cell niche
by: V. V. Zhdanov, et al.
Published: (2024-04-01) -
Evaluation of the renal function among sickle cell patients: a cross-sectional study
by: Talal Qadah, et al.
Published: (2025-03-01)